JPWO2024043334A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2024043334A5
JPWO2024043334A5 JP2024542889A JP2024542889A JPWO2024043334A5 JP WO2024043334 A5 JPWO2024043334 A5 JP WO2024043334A5 JP 2024542889 A JP2024542889 A JP 2024542889A JP 2024542889 A JP2024542889 A JP 2024542889A JP WO2024043334 A5 JPWO2024043334 A5 JP WO2024043334A5
Authority
JP
Japan
Prior art keywords
group
optionally substituted
amino
piperazin
ethan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024542889A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2024043334A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/030733 external-priority patent/WO2024043334A1/ja
Publication of JPWO2024043334A1 publication Critical patent/JPWO2024043334A1/ja
Publication of JPWO2024043334A5 publication Critical patent/JPWO2024043334A5/ja
Pending legal-status Critical Current

Links

JP2024542889A 2022-08-26 2023-08-25 Pending JPWO2024043334A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022135257 2022-08-26
PCT/JP2023/030733 WO2024043334A1 (ja) 2022-08-26 2023-08-25 新規なピペラジン誘導体又はその塩及び医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2024043334A1 JPWO2024043334A1 (https=) 2024-02-29
JPWO2024043334A5 true JPWO2024043334A5 (https=) 2025-05-09

Family

ID=90013519

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024542889A Pending JPWO2024043334A1 (https=) 2022-08-26 2023-08-25

Country Status (6)

Country Link
US (1) US20250326744A1 (https=)
EP (1) EP4578849A4 (https=)
JP (1) JPWO2024043334A1 (https=)
CN (1) CN119816484A (https=)
AU (1) AU2023331216A1 (https=)
WO (1) WO2024043334A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025178125A1 (ja) * 2024-02-22 2025-08-28 富士フイルム株式会社 新規なピペラジン誘導体又はその塩

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09241241A (ja) * 1996-03-08 1997-09-16 Roussel Morishita Kk N−(1−置換−4−ピペリジル)ベンズアミド誘導体
US20050009843A1 (en) * 2001-04-26 2005-01-13 Kiyoshi Nakayama Medicine for inhibiting drug elimination pump
US6689782B2 (en) * 2001-07-16 2004-02-10 Essential Therapeutics, Inc. Fungal efflux pump inhibitors
CN1158270C (zh) * 2001-09-26 2004-07-21 四川大学 具有钙离子拮抗作用的双哌嗪类衍生物
JP2005162726A (ja) * 2003-01-24 2005-06-23 Tanabe Seiyaku Co Ltd ピラゾロピリミジン化合物およびその製法
US7851474B2 (en) * 2005-08-02 2010-12-14 Neurogen Corporation Dipiperazinyl ketones and related analogues
KR20080061613A (ko) * 2006-12-28 2008-07-03 (주) 비엔씨바이오팜 2-(메틸티오)피리미딘 유도체, 그 제조방법 및 이를포함하는 항바이러스용 약학적 조성물
CN101070308B (zh) * 2007-06-19 2011-05-04 天津药物研究院 异噁唑啉衍生物及其用途
CN101361741B (zh) * 2008-09-22 2011-07-27 天津药物研究院 异噁唑啉类衍生物抗肿瘤新用途
CN104610160A (zh) * 2013-11-04 2015-05-13 南京大学 含哌嗪环的5-硝基咪唑类衍生物及其制备与在抗菌药物中的应用
MX2021004191A (es) * 2018-10-15 2021-05-27 Nurix Therapeutics Inc Compuestos bifuncionales para degradar la tirosina cinasa de bruton (btk) mediante la trayectoria de ubiquitina proteosoma.
WO2021113557A1 (en) * 2019-12-04 2021-06-10 Nurix Therapeutics, Inc. Bifunctional compounds for degrading btk via ubiquitin proteosome pathway
CN113527227B (zh) * 2020-04-15 2024-06-21 四川弘远药业有限公司 一种卡利拉嗪的制备方法
WO2022047008A1 (en) * 2020-08-26 2022-03-03 Tarveda Therapeutics, Inc. Hsp90-binding conjugates and formulations thereof
CN112358466B (zh) * 2020-10-10 2021-10-26 广东省微生物研究所(广东省微生物分析检测中心) 1,2,4-三唑-诺氟沙星杂合体及其制备方法和应用
CN112592339B (zh) * 2020-12-22 2022-06-07 广东省微生物研究所(广东省微生物分析检测中心) 1,3,4-恶二唑-2(3h)-硫酮-诺氟沙星杂合体及其制备方法和应用
WO2023055952A1 (en) * 2021-09-29 2023-04-06 C4 Therapeutics, Inc. Neurotrophic tyrosine receptor kinase (ntrk) degrading compounds

Similar Documents

Publication Publication Date Title
RU2440330C2 (ru) ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА, КАК АГОНИСТЫ β2 АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
JPWO2024043334A5 (https=)
JP2021529812A5 (https=)
JP2004516293A5 (https=)
JP2005533073A5 (https=)
JP2005523310A5 (https=)
JP2010520307A5 (https=)
JP2004538285A5 (https=)
FR2840897A1 (fr) Nouveaux derives d'arylsulfonamides et leur utilisation en therapeutique
RU2007134380A (ru) Антибактериальные производные пиперидина
JP2005533071A5 (https=)
JP2009541489A5 (https=)
RU2004137279A (ru) Производные дифенилазетидинона для лечения нарушений метаболизма липидов
JP2014508720A5 (https=)
JP2004115534A5 (https=)
JP2013542213A5 (https=)
JP2021515004A5 (https=)
JP2016516028A5 (https=)
RU2007147344A (ru) Новые производные 2-азетидинона для лечения гиперлипидемических заболеваний
RU2011109435A (ru) Пиперидиновые соединения, содержащая их фармацевтическая композиция и ее применение
RU2007147338A (ru) Новые производные 2-азетидинона и их применение в качестве ингибиторов всасывания холестерина для лечения гиперлипидемии
JP2006501248A5 (https=)
RU2401267C2 (ru) Замещенные производные бензохинолизина
JPWO2021066149A5 (https=)
MA26858A1 (fr) Acides ox(adi)azolyl-hydroxamiques utiles comme inhibiteurs de procollagene c-proteinase.